Skip to content

Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampness

Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampness

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003426
Enrollment
Unknown
Registered
2020-06-24
Start date
2020-06-19
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Cases that meet the diagnostic criteria of Western medicine, clinical diagnosis and TCM dampness syndrome diagnosis; 2. Patients who meet the criteria of ulcerative colitis in mild and moderate active stage; 3. Patients who sign informed consent and have good compliance can be followed up; 4. Outpatients or inpatients aged between 18 and 70 years; 5. Patients who do not use drugs or other treatments that affect the efficacy evaluation during the treatment.

Exclusion criteria

Exclusion criteria: 1. Chronic schistosomiasis, bacillary dysentery, intestinal tuberculosis and other infectious colitis and colon Crohn's disease, radiation enteritis and ischemic enteritis; 2. Lactation, pregnant women and patients who are intolerant to the drug; 3. Patients with serious primary diseases such as heart, lung, liver, kidney and hematopoietic system, and psychosis; 4. Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease; 5. Disabled patients (dumb, deaf, blind, mental disorder, physical disability, mental disorder) as prescribed by law.

Design outcomes

Primary

MeasureTime frame
Disease relief;

Secondary

MeasureTime frame
Inflammatory Bowel Disease Quality of Life Questionnaire;Changes in wet syndrome points;Single symptom efficacy;Microscopic intestinal mucosa score;UC Disease Activity Index;

Countries

China

Contacts

Public ContactHuang Shaogang

Guangdong Provincial Hospital of Traditional Chinese Medicine

huangshaogang@gzucm.edu.cn+86 13926451320

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026